In an in vivo model of diabetic retinopathy, PLA2 was significantly activated, resulting in the breakdown of the blood–retinal barrier (BRB) caused by the damage to endothelial cells (ECs) and pericytes (PCs), both cellular components of retinal microvessels [70]. This evidence concerns the gene PLA2G6 and diabetic retinopathy.